🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Gram-negative Bacteremia

Fosfomycin I.v. for Treatment of Severely Infected Patients NCT02979951n/a50 sites📍 Hall in Tirol📍 Reutte📍 Vienna Infectopharm Arzneimittel GmbH A Platform Trial for Gram Negative Bloodstream Infections NCT06537609NA39 sites📍 Kogarah📍 New Lambton📍 Herston Sunnybrook Health Sciences Centre · Tests: De-escalation VS No De-escalation, Oral beta-lactams VS non beta-lactams, Central vascular catheter retention VS Centra… Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial NCT06080698NA11 sites📍 San Francisco📍 Denver📍 Baltimore Johns Hopkins University · Tests: Intravenous Antibiotics, Oral Antibiotics Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV NCT06135350Phase 22 sites📍 Moscow📍 Moscow Gamaleya Research Institute of Epidemiology and Microbiolog… · Tests: Fluorothiazinone, tablets 300 mg at a dose of 2400 mg/day, Placebo Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis NCT03044223n/a1 site📍 Ulm University of Ulm A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection NCT06966284n/a1 site📍 Taipei TTY Biopharm Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients NCT07372131NA1 site📍 Rozzano Valeria Cento · Tests: Clinical Stability-Driven Antibiotic Discontinuation Strategy, Standard of Care Antibiotic Duration PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) NCT03671967Phase 414 sites📍 Calgary📍 Surrey📍 St. John's Rambam Health Care Campus · Tests: Piperacillin/tazobactam, Meropenem The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST) NCT07491419NA1 site📍 Rozzano Istituto Clinico Humanitas · Tests: Diagnostic Test: Rapid Antimicrobial Susceptibility Testing (R-AST) guided Stewardship, Standard of Care (SOC)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy